HDGF and neoplasm: Since angiogenesis is closely related to tumor metastasis, it can be a novel therapeutic strategy to combine compound C108 with antiangiogenic agents or antibodies against HDGF in the treatment of metastatic ESCC, which may achieve better treatment effects.